December 23, 2021
FDA director-general Eric Domingo also assured that adverse events observed during clinical trials are mild.
FDA director-general Eric Domingo also assured that adverse events observed during clinical trials are mild.
December 23, 2021
FDA director-general Eric Domingo also assured that adverse events observed during clinical trials are mild.